m+Medelevator.RU
← Поиск публикаций
The Journal of biological chemistry · 2026

Site-specific m1A Installation by the MTR1 Ribozyme and Modulation of Mitochondrial mRNA Translation in vitro.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Xie Yuting, Zhao Zhuoya, Deng Jie, Zhao Yingying, Fu Bo, He Yuanlin, Zhang Xiaorong, Huang Lin

Аннотация

RNA modifications play essential roles in regulating RNA structure, stability, and translation. Among these, m1A is a functionally important modification that influences Watson-Crick base pairing and translational fidelity. However, approaches for site-specific installation and func tional interrogation of m1A in RNA remain limited. Here, we characterize the catalytic properties of the methyltransferase ribozyme MTR1 with a focus on donor compatibility, sequence-dependent kinetics, and activity on structured RNA substrates. We show that MTR1 catalyzes alkyl transfer from O6-methylguanine- derived donors to adenosine residues in RNA and accommodates fluorophore-conjugated donors for covalent RNA labeling. Target-site mutation and reverse transcription-based analyses further validate the adenosine-dependent specificity of MTR1-mediated transfer. Comparative kinetic analyses under mildly acidic (pH 6.0) and alkaline (pH 7.5) conditions reveal that pH is a key determinant of MTR1 catalytic efficiency across sequence contexts. Although local sequence context influences reaction rates, pH 6.0 substantially enhances catalytic activity across tested substrates, enabling efficient modification of sequences with limited activity under pH 7.5 conditions. These findings indicate that sequence preference primarily affects reaction kinetics rather than modification capability under mildly acidic conditions, expanding the practical sequence compatibility of MTR1-mediated RNA modification. We further demonstrate that MTR1 enables site-specific m1A modification in structured mitochondrial mRNAs, including mouse COX2 and human ATP8 transcripts, and that these modifications reduce translation in a cell-free mitochondrial system. Together, these results define the donor compatibility, sequence-dependent kinetics, and substrate scope of MTR1 and provide insights into ribozyme-mediated RNA alkylation chemistry.